Search
Now showing items 1-10 of 1216
Therapeutic Equivalence of Alendronate 70 mg Once-Weekly and Alendronate 10 mg Daily in the Treatment of Osteoporosis. Alendronate Once-Weekly Study Group
Schnitzer, T.; Bone, H. G.; Crepaldi, G.; Adami, S.; McClung, M.; Kiel, D., et al. (2000). Therapeutic Equivalence of Alendronate 70 mg Once-Weekly and Alendronate 10 mg Daily in the Treatment of Osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano), February 2000, 12(1):1-12. doi: http://dx.doi.org/10.1007/bf03339822
Hyperresponsive Airway - Preface
Townley, RG. (2003). Hyperresponsive Airway - Preface. Clin Rev Allergy Immunol, February 2003, 24(1):1-5. doi: http://dx.doi.org/10.1385/CRIAI:24:1:1
Both Heads of Tissue-Derived Smooth Muscle Heavy Meromyosin Bind to Actin in the Presence of ADP
Ellison, P. A.; DePew, Z. S.; Cremo, C. R. (2003). Both Heads of Tissue-Derived Smooth Muscle Heavy Meromyosin Bind to Actin in the Presence of ADP. J Biol Chem, 2003, 278(7):4410-4415. doi: http://dx.doi.org/10.1074/jbc.M211016200
Vitamin D: How Much do we Need, and how Much is Too Much?
Heaney, R. P. (2000). Vitamin D: How Much do we Need, and how Much is Too Much? Osteoporos Int, August 2000, 11(7):553-555. doi: http://dx.doi.org/10.1007/s001980070074
Calcium, Dairy Products and Osteoporosis
Heaney, R. P. (2000). Calcium, Dairy Products and Osteoporosis. J Am Coll Nutr, April 2000, 19(2 Supplement):83S-99S. doi: http://dx.doi.org/10.1080/07315724.2000.10718088
Genetic Variations in Bone Density, Histomorphometry, and Strength in Mice
Akhter, M. P.; Iwaniec, U. T.; Covey, M. A.; Cullen, D. M.; Kimmel, D. B.; Recker, R. R. (2000). Genetic Variations in Bone Density, Histomorphometry, and Strength in Mice. Calcif Tissue Int, October 2000, 67(4):337-344. doi: http://dx.doi.org/10.1007/s002230001144
Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density. Alendronate/Estrogen Study Group
Bone, H. G.; Greenspan, S. L.; McKeever, C.; Bell, N.; Davidson, M.; Downs, R. W., et al. (2000). Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab, February 2000, 85(2):720-726. doi: http://dx.doi.org/10.1210/jcem.85.2.6393
Association of Estrogen Receptor-Alpha Genotypes with Body Mass Index in Normal Healthy Postmenopausal Caucasian Women
Deng, H. W.; Li, J.; Li, J. L.; Dowd, R.; Davies, K. M.; Johnson, M., et al. (2000). Association of Estrogen Receptor-Alpha Genotypes with Body Mass Index in Normal Healthy Postmenopausal Caucasian Women. J Clin Endocrinol Metab, August 2000, 85(8):2748-2751. doi: http://dx.doi.org/10.1210/jcem.85.8.6728
Genetic Determination of Colles' Fracture and Differential Bone Mass in Women with and without Colles' Fracture
Deng, H. W.; Chen, W. M.; Recker, S.; Stegman, M. R.; Li, J. L.; Davies, K. M., et al. (2000). Genetic Determination of Colles' Fracture and Differential Bone Mass in Women with and without Colles' Fracture. J Bone Miner Res, July 2000, 15(7):1243-1252. doi: http://dx.doi.org/10.1359/jbmr.2000.15.7.1243
Determination of Bone Mineral Density of the Hip and Spine in Human Pedigrees by Genetic and Life-Style Factors
Deng, H. W.; Chen, W. M.; Conway, T.; Zhou, Y.; Davies, K. M.; Stegman, M. R.; Deng, H.; Recker, R. R. (2000). Determination of Bone Mineral Density of the Hip and Spine in Human Pedigrees by Genetic and Life-Style Factors. Genet Epidemiol, September 2000, 19(2):160-177. doi: http://dx.doi.org/10.1002/1098-2272(200009)19:2<160